Closing Out and What You Leave Behind

Part of Clinical Project Management (PM) Training: Inspection Readiness and Close-Out.

About 2 minutes. Free, in your language, no account needed.

Close-out is a set of obligations, not an ending

Sites are closed formally, with a visit that confirms drug is reconciled and returned or destroyed, records are complete and retained, and the site knows its retention obligations.

Essential documents are retained for the period the applicable regulations require, which is years, and the sites must be told how long and be able to comply.

Participants must know what happens next: whether results will be shared, whether any follow-up continues, and who to contact.

Drug accountability closes or it does not

Every unit shipped is accounted for: dispensed, returned, destroyed or still on the shelf. A discrepancy at close-out is very hard to resolve, because the people who handled it have often moved on.

This is why accountability is reconciled during the trial rather than at the end.

Results have to be reported

Registry results posting and publication are obligations with deadlines, not courtesies. A trial that enrolled participants and never reported has taken something from them and given nothing back, and in most jurisdictions it has also broken a rule.

The handover nobody plans

Trials outlive the people who run them. The next person needs to be able to reconstruct not only what was done but why: why that site was closed, why that deviation was classified as it was, why the timeline was re-baselined in month fourteen.

Decisions recorded with their reasons are the thing that makes a trial defensible years later. That record is the most durable part of the job, and it is built a day at a time or not at all.